|
| Press Releases |
|
 |
|
| Thursday, June 29, 2023 |
|
|
BioMed X Institute Starts Its First Research Project With Sanofi on Artificial Intelligence for Drug Development |
| BioMed X, a German independent research institute, announces the start of its first research project in collaboration with Sanofi: "Next Generation Virtual Patient Engine for Clinical Translation of Drug Candidates" (VPE). more info >> |
|
| Thursday, April 27, 2023 |
|
|
BioMed X Launches XSeed Labs in the US with Boehringer Ingelheim - a New Model for Building an External Innovation Ecosystem on an Industry Campus |
| BioMed X announced today the expansion of its collaboration with Boehringer Ingelheim with the launch of a new model for biomedical research: XSeed Labs. more info >> |
|
|
BioMed X Launches XSeed Labs in the US with Boehringer Ingelheim - a New Model for Building an External Innovation Ecosystem on an Industry Campus |
| BioMed X announced today the expansion of its collaboration with Boehringer Ingelheim with the launch of a new model for biomedical research: XSeed Labs. more info >> |
|
| Tuesday, April 4, 2023 |
|
|
BioMed X and Merck Expand Collaboration Aiming to Leverage Cancer-Specific Vulnerabilities for Targeted Therapies |
| BioMed X, an independent biomedical research institute, announces the start of its new research project - "New Strategies to Enhance the Immunogenicity of Tumors" - in collaboration with Merck. The focus of this new research group will be to develop novel approaches for enhancing tumor immunogenicity to broaden the population of patients who could benefit from cancer immunotherapy. more info >> |
|
|
BioMed X and Merck Expand Collaboration Aiming to Leverage Cancer-Specific Vulnerabilities for Targeted Therapies |
| BioMed X, an independent biomedical research institute, announces the start of its new research project - "New Strategies to Enhance the Immunogenicity of Tumors" - in collaboration with Merck. The focus of this new research group will be to develop novel approaches for enhancing tumor immunogenicity to broaden the population of patients who could benefit from cancer immunotherapy. more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
Q2 Metals Announces Warrant Exercise for $7.6 Million
Feb 28, 2025 15:58 HKT/SGT
|
|
|
Fujitsu's Oyama plant achieves top CSR score for sustainability in global telecom audit
Feb 28, 2025 16:57 JST
|
|
|
HKTDC welcomes Hong Kong SAR's 2025-26 Budget
Feb 28, 2025 15:54 HKT/SGT
|
|
|
Honda、軽二輪スーパースポーツモデル「CBR250RR」のカラーバリエーションを変更し発売
Feb 28, 2025 15:00: JST
|
|
|
三菱重工、ポジティブ・インパクト・ファイナンス融資契約を締結
Feb 28, 2025 15:00: JST
|
|
|
Eisai Enters into License Agreement for the Development and Distribution of Fibroblast Growth Factor (FGF) Receptor Selective Tyrosine Kinase Inhibitor Tasurgratinib in Greater China Region (Mainland China, Hong Kong, Macau, and Taiwan) with SciClone
Feb 28, 2025 12:31 JST
|
|
|
NEC introduces solution to enhance the security of Open vRAN
Feb 28, 2025 11:30 JST
|
|
|
エーザイ、線維芽細胞増殖因子受容体（FGFR）選択的チロシンキナーゼ阻害剤タスルグラチニブについて中国・香港・マカオ・台湾での開発・販売に関するライセンス契約をSciCloneと締結
Feb 28, 2025 10:00: JST
|
|
|
MovieCoin (MOV) Shaping the Future of Film Investment with Winvest Group
Feb 27, 2025 22:30: JST
|
|
|
中国最大民营黄金生产商赤峰吉隆黄金矿业 公布于香港主板上市计划详情
Feb 27, 2025 22:28 HKT/SGT
|
|
|
Chifeng Jilong Gold Mining, the Largest Non-State Owned Gold Producer in China, Announces Details of Proposed Listing on the Main Board of HKEX
Feb 27, 2025 21:44 HKT/SGT
|
|
|
MovieCoin (MOV) Shaping the Future of Film Investment with Winvest Group
Feb 27, 2025 21:30 HKT/SGT
|
|
|
中國最大民營黃金生產商赤峰吉隆黃金礦業 公佈於香港主板上市計劃詳情
Feb 27, 2025 21:27 HKT/SGT
|
|
|
迪拜高层代表团一行参访君圣泰医药 解码中国医药创新范式
Feb 27, 2025 21:01 HKT/SGT
|
|
|
The 17th Annual Global CSR & ESG Summit 2025 Concludes in Ho Chi Minh City, Setting New Standards in Sustainability
Feb 27, 2025 20:47 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
